The European Antitrust Review 2016

European Union: Pharmaceuticals

14 July 2015

The pharmaceutical sector has continued to be under competition scrutiny this year, both in the context of behavioural investigations and the review of transactions. Much of the behavioural activity this year was at member state level, with the Italian Supreme Administrative Court taking an approach to a patent holder’s request for a divisional patent and related supplementary protection certificate that surprised many.

Interested in becoming a GCR author? Please contact our Insight Manager.

Get in touch